Pace Life Sciences

The supplied evidence does not describe any company, product brand, or platform called Pace Life Sciences. The only material provided consists of news articles about a lawsuit concerning Truth Social and early access to posts by President Donald Trump's media company. That content has no connection to a life-sciences brand, so no reliable facts about Pace Life Sciences — its ownership, headquarters, founding, products, or market position — can be established from the evidence. Because the name could plausibly refer to a life-sciences services or laboratory company, but no official website, Wikipedia entry, or brand-sense source was supplied, this entry is intentionally left minimal. It should be treated as a placeholder pending verification. No products, executives, milestones, or financial details are asserted here, since doing so would require inventing information. If a verified source is later provided (for example an official corporate site or a Wikipedia article about the company), this dossier should be rewritten with a full bilingual history, product list, ownership structure, and taxonomy classification.

• 2026.08.13

  Reported2026.08.13

  Pace appoints Andy Fenny as President of Pace Life Sciences[1]Pace任命Andy Fenny为Pace Life Sciences总裁finanznachrichten.de

  Pace, a Science and Technology company, appointed Andrew (Andy) Fenny as President of Pace Life Sciences, its life sciences division, to lead the business into its next phase of strategic growth with a focus on expanding support and capacity for pharmaceutical and biotech clients across the development cycle. Fenny, based in Research Triangle Park, North Carolina, brings over two decades of CDMO and pharmaceutical experience, having previously served as Chief Commercial Officer at SK Pharmteco and Chief Business Officer at FUJIFILM Diosynth Biotechnologies.

Read more

1. 1Pace任命Andy Fenny为Pace Life Sciences总裁finanznachrichten.de